Objective Pancreatic cancer is a globally frequent cause of death, which can be caused by
many factors. This meta-analysis was performed to assess the correlation between …

Hepatocellular carcinoma (HCC) and metabolic syndrome (MetS) have a rising prevalence
worldwide. The relationship between these two entities has long been studied and …

Metabolic syndrome may contribute to the rising incidence of multiple gastrointestinal (GI)
cancers in recent birth cohorts. However, other than hepatocellular carcinoma, the …

Gastric cancer (GC) ranks fifth in incidence and fourth in mortality worldwide. The high death
rate in patients with GC requires new biomarkers for improving survival estimation. In this …

Background: Insulin resistance (IR) is assessed using surrogate markers such as the
triglyceride–glucose (TyG) index, the triglyceride-to-high-density lipoprotein cholesterol …

Metabolic disorders, including obesity, dyslipidemia, diabetes, nonalcoholic fatty liver
disease, and metabolic syndrome, are characterized by insulin resistance, abnormalities in …

Metabolic dysfunction-associated steatotic liver disease (MASLD) poses a significant and
ever-increasing health and economic burden worldwide. Substantial epidemiological …

Objective Although metabolic abnormalities are implicated in the etiology of
neurodegenerative diseases, their role in the development of amyotrophic lateral sclerosis …

Metabolic syndrome (MetS) is a group of several metabolic conditions predisposing to
chronic diseases. Individuals diagnosed with MetS are physiologically heterogeneous, with …

Background Little is known about applying machine learning (ML) techniques to identify the
important variables contributing to the occurrence of gastrointestinal (GI) cancer in …